Related references
Note: Only part of the references are listed.Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): Kinase profiling guided optimization of a 1,2,3-benzotriazole lead
Wylie S. Palmer et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): Optimization for JNK potency and physicochemical properties
Leyi Gong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Hit-to-lead optimization and kinase selectivity of imidazo[1,2-a]quinoxalin-4-amine derived JNK1 inhibitors
Bei Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Asthmatic airway smooth muscle CXCL10 production: mitogen-activated protein kinase JNK involvement
Yazan A. Alrashdan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)
Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis
Nicole Reich et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Discovery of a novel series of 4-quinolone JNK inhibitors
Leyi Gong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury
Veronique Plantevin Krenitsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor
Veronique Plantevin Krenitsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Role of JNK in Mammary Gland Development and Breast Cancer
Cristina Cellurale et al.
CANCER RESEARCH (2012)
Discovery of Potent and Selective Covalent Inhibitors of JNK
Tinghu Zhang et al.
CHEMISTRY & BIOLOGY (2012)
JNK3 Perpetuates Metabolic Stress Induced by Aβ Peptides
Sung Ok Yoon et al.
NEURON (2012)
JNK-1 Deficiency Limits Macrophage-Mediated Antigen-Induced Arthritis
Monica Guma et al.
ARTHRITIS AND RHEUMATISM (2011)
Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase
Surya K. De et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Highly selective c-Jun N-terminal kinase (JNK) 3 inhibitors with in vitro CNS-like pharmacokinetic properties II. Central core replacement
R. Jeffrey Neitz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor
Simeon Bowers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) Inhibitors
Yuanjun He et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration
Simeon Bowers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitors
Romain Noel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Synthesis and SAR of 2-Phenoxypyridines as novel c-Jun N-terminal kinase inhibitors
Xinyi Song et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Levodopa Activates Apoptosis Signaling Kinase 1 (ASK1) and Promotes Apoptosis in a Neuronal Model: Implications for the Treatment of Parkinson's Disease
Elizabeth A. Sabens Liedhegner et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors
Surya K. De et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK
Roy K. Hom et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
The c-Jun N-terminal kinase inhibitor SP600125 is neuroprotective in amygdala kindled rats
Xu Chen et al.
BRAIN RESEARCH (2010)
Characterization of immune cell subsets during the active phase of multiple sclerosis reveals disease and c-Jun N-terminal kinase pathway biomarkers
Chiara Ferrandi et al.
Multiple Sclerosis Journal (2010)
Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease
Steven P. Braithwaite et al.
NEUROBIOLOGY OF DISEASE (2010)
cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance
Guadalupe Sabio et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Discovery of 2-(5-nitrothiazol-2-ylthio) benzo[d] thiazoles as novel c-Jun N-terminal kinase inhibitors
Surya K. De et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
1-Aryl-3,4-dihydroisoquinoline inhibitors of JNK3
John A. Christopher et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors
Youseung Shin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Structure-Activity Relationships and X-ray Structures Describing the Selectivity of Aminopyrazole Inhibitors for c-Jun N-terminal Kinase 3 (JNK3) over p38
Ted Kamenecka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Design, Synthesis, and Structure-Activity Relationship of Substrate Competitive, Selective, and in Vivo Active Triazole and Thiadiazole Inhibitors of the c-Jun N-Terminal Kinase
Surya K. De et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
JNK regulates APP cleavage and degradation in a model of Alzheimer's disease
Alessio Colombo et al.
NEUROBIOLOGY OF DISEASE (2009)
Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1)
Yasutomi Asano et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (2)
Yasutomi Asano et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation
Lijian Hui et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
JNK signaling in apoptosis
D. N. Dhanasekaran et al.
ONCOGENE (2008)
Identification of a new JNK inhibitor targeting the JNK-JIP interaction site
John L. Stebbins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
3,5-Disubstituted quinolines as novel c-Jun N-terminal kinase inhibitors
Rong Jiang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
A pathogenic role for JNK signaling in experimental anti-GBM glomerulonephritis
R. S. Flanc et al.
KIDNEY INTERNATIONAL (2007)
Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors
Mahbub Alam et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3
Richard M. Angell et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Discovery of a new class of 4-anilinopyrimidines as potent c-Jun N-terminal kinase inhibitors: Synthesis and SAR studies
Mei Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
The role of c-Jun N-terminal kinase, p38, and extracellular signal-regulated kinase in insulin-induced Thr69 and Thr71 phosphorylation of activating transcription factor 2
Bart Baan et al.
MOLECULAR ENDOCRINOLOGY (2006)
The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death
Jun-Ying Zhou et al.
CANCER RESEARCH (2006)
The JNK are important for development and survival of macrophages
SR Himes et al.
JOURNAL OF IMMUNOLOGY (2006)
A signaling mechanism from Gαq-protein-coupled metabotropic glutamate receptors to gene expression:: Role of the c-Jun N-terminal kinase pathway
L Yang et al.
JOURNAL OF NEUROSCIENCE (2006)
c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases
A Sprowles et al.
EXPERIMENTAL CELL RESEARCH (2005)
Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase
P Gaillard et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes
H Kaneto et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Islet-Brain (IB)/JNK-interacting proteins (JIPs): Future targets for the treatment of neurodegenerative diseases?
N Moulin et al.
CURRENT NEUROVASCULAR RESEARCH (2004)
JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease
S Hunot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The ASK1-MAP kinase cascades in mammalian stress response
J Matsukawa et al.
JOURNAL OF BIOCHEMISTRY (2004)
c-Jun N-terminal kinase mediates hepatic injury after rat liver transplantation
T Uehara et al.
TRANSPLANTATION (2004)
Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats
C Ferrandi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
AS601245 (1,3-benzothiazol-2-yl(2-{[2-(3-pyridinyl)ethyl]amino}-4 pyrimidinyl) acetonitrile):: A c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties
S Carboni et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Targeting JNK3 for the treatment of neurodegenerative disorders
L Resnick et al.
DRUG DISCOVERY TODAY (2004)
被撤回的出版物: c-Src is activated by the epidermal growth factor receptor in a pathway that mediates JNK and ERK activation by gonadotropin-releasing hormone in COS7 cells (Retracted article. See vol. 292, pg. 8851, 2017)
S Kraus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
JNK: a new therapeutic target for diabetes
BL Bennett et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
The scaffold protein IB1/JIP-1 is a critical mediator of cytokine-induced apoptosis in pancreatic β cells
JA Haefliger et al.
JOURNAL OF CELL SCIENCE (2003)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
Endothelin suppresses cell migration via the JNK signaling pathway in a manner dependent upon Src kinase, Rac1, and Cdc42
J Yamauchi et al.
FEBS LETTERS (2002)
Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis
ZN Han et al.
ARTHRITIS AND RHEUMATISM (2002)
Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease
XW Zhu et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Share Paper
